A business in context
RGNX research notebook
Read the disclosures. Follow the relationships. Keep the dates in view.
Filing timeline
Download filings CSVReported insider transactions
Download transactions CSVP · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift
| Transaction / filed | Reporting owner | Type | Security | Shares | Reported price |
|---|---|---|---|---|---|
| 2026-09-01 | Malzahn Craig | F · Tax / exercise payment | Common Stock | 234.0 | 9.32 |
| 2026-09-01 | Chan Mitchell | F · Tax / exercise payment | Common Stock | 4902.0 | 9.32 |
| 2026-08-27 | Ciongoli Gregory Austin | P · Purchase | Common Stock | 53407.0 | 9.36 |
| 2026-08-26 | Ciongoli Gregory Austin | P · Purchase | Common Stock | 49196.0 | 9.14 |
| 2026-08-25 | Ciongoli Gregory Austin | A · Grant / award | Common Stock | 15432.0 | 0.0 |
| 2026-08-25 | Ciongoli Gregory Austin | A · Grant / award | Stock Options (Right to buy) | 69609.0 | 0.0 |
| 2026-08-01 | PAKOLA STEVE | F · Tax / exercise payment | Common Stock | 7468.0 | 9.69 |
| 2026-08-01 | Christmas Patrick J. | F · Tax / exercise payment | Common Stock | 4699.0 | 9.69 |
| 2026-07-02 | PAKOLA STEVE | S · Sale | Common Stock | 2161.0 | 13.64 |
| 2026-07-02 | PAKOLA STEVE | M · Exercise / conversion | Common Stock | 2161.0 | 7.86 |
| 2026-07-02 | PAKOLA STEVE | M · Exercise / conversion | Stock Options (Right to Buy) | 2161.0 | 0.0 |
| 2026-07-01 | PAKOLA STEVE | S · Sale | Common Stock | 36725.0 | 12.86 |
| 2026-07-01 | PAKOLA STEVE | M · Exercise / conversion | Common Stock | 36725.0 | 7.86 |
| 2026-07-01 | PAKOLA STEVE | M · Exercise / conversion | Stock Options (Right to Buy) | 36725.0 | 0.0 |
| 2026-07-01 | Simpson Curran | F · Tax / exercise payment | Common Stock | 6818.0 | 13.09 |
| 2026-06-30 | Simpson Curran | A · Grant / award | Common Stock | 1453.0 | 10.18 |
| 2026-06-29 | PAKOLA STEVE | S · Sale | Common Stock | 19608.0 | 11.04 |
| 2025-12-31 | Simpson Curran | A · Grant / award | Common Stock | 951.0 | 7.0 |
Identity & relationships
SEC issuer · 0001590877REGENXBIO Inc.
Search names and former names
- ReGenX Biosciences, LLC · former SEC name · 2013-11-07 to 2013-11-07
Revenue in constant purchasing power
| Year ended | Reported USD revenue | CPI-adjusted USD revenue |
|---|---|---|
| 2024-12-31 | $83.33M | $89.50M |
| 2023-12-31 | $90.24M | $99.78M |
| 2022-12-31 | $112.72M | $129.76M |
| 2021-12-31 | $470.35M | $584.76M |
| 2020-12-31 | $154.57M | $201.23M |
| 2019-12-31 | $35.23M | $46.43M |
| 2018-12-31 | $218.50M | $293.18M |
| 2017-12-31 | $10.39M | $14.29M |